Reprogrammed metabolism is a hallmark of cancer. However, the metabolic dependency of
cancer, from tumour initiation through disease progression and therapy resistance, requires …

The incidence of prostate cancer (PCa) displays widespread regional differences, probably
owing to differences in dietary habits. Nutrients, including fat, protein, carbohydrates …

Metabolic reprogramming is a hallmark of cancer. However, it is not well known how
metabolism affects cancer progression. We identified that metabolic enzyme acyl-CoA …

Growing evidence of the microbiome's role in human health and disease has emerged since
the creation of the Human Microbiome Project. Recent studies suggest that alterations in …

Saturated fatty acids possess few health benefits compared to unsaturated fatty acids.
However, increasing experimental evidence demonstrates the nutritionally beneficial role of …

Diet bioactive components, in the concept of nutrigenetics and nutrigenomics, consist of food
constituents, which can transfer information from the external environment and influence …

Despite key advances in the treatment of prostate cancer (PCa), a proportion of men have
de novo resistance, and all will develop resistance to current therapeutics over time …

Nonalcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver disease
globally. NAFLD is a consequence of fat accumulation in the liver leading to lipotoxicity …

Nowadays, molecular research is essential for the better understanding of tumor cells'
pathophysiology. The increasing number of neoplasms is taken under 'the molecular …

The categorization of cancers demonstrates that prostate cancer is the most common
malignancy in men and it causes high death annually. Prostate cancer patients are …